Reza Khorshidi-Khiavi

Reza Khorshidi-Khiavi

Auto-generated profile, based on publicly available information

Reza Khorshidi-Khiavi

Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
BBBehnam Bohluli
Behnam Bohluli
BSBernhard J. Schaller
Bernhard J. Schaller
RKReza Khorshidi-Khiavi
Reza Khorshidi-Khiavi
MDMohsen Dalband
Mohsen Dalband
PSPooyan Sadr-Eshkevari
Pooyan Sadr-Eshkevari
PMPeter Maurer
Peter Maurer

1 January 2019 in Journal of Clinical and Experimental Dentistry
Verified
Journal Article
Open access
JYJavad Yazdani
Javad Yazdani
RKR Khorshidi-Khiavi
R Khorshidi-Khiavi
SNS Nezafati
S Nezafati
AMA Mortazavi
A Mortazavi
FFF Farhadi
F Farhadi
MGM Ghanizadeh
M Ghanizadeh
Similarity of pharmacokinetics of intranasal ketorolac to the intravenous form and other advantages have promoted its application. This study compared the analgesic effects of intravenous and intranasal ketorolac in patients undergoing mandibular fracture surgery. In this clinical trial study, Sixty-four patients with unilateral mandibular fracture were divided randomly into two groups. In group 1, 30 mg of intravenous (IV) ketorolac was injected every 8 hours and in group 2, intranasal (IN) ketorolac spray was used as a 100-µL puff in each nostril (31.5 mg) every 6 hours. After each patient regained consciousness, pain intensity was measured based on visual analogue scale for 48 hours. Finally, the total dose of the opioid analgesic agent (pethidine) and the time for the first request for an analgesic agent were recorded for each patient, and their means were compared in each group with proper statistical tests. Mean pain intensity of patients at baseline was significantly higher than that at other intervals and then, it decreased significantly (P<0.001). Furthermore, 2, 4, 6 and 8 hours after surgery, mean pain intensity in the IN group was significantly lower than that in the IV group (P0.05). Application of intranasal ketorolac spray decreased pain after mandibular fracture surgery, especially at 8-hour interval after surgery, decreasing the need for opioids. Key words:Ketorolac, intranasal, intravenous, mandibular fracture.